1. Home
  2. COEP vs MTEN Comparison

COEP vs MTEN Comparison

Compare COEP & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • MTEN
  • Stock Information
  • Founded
  • COEP 2017
  • MTEN 2015
  • Country
  • COEP United States
  • MTEN China
  • Employees
  • COEP N/A
  • MTEN N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • MTEN Building Products
  • Sector
  • COEP Health Care
  • MTEN Industrials
  • Exchange
  • COEP Nasdaq
  • MTEN Nasdaq
  • Market Cap
  • COEP 32.4M
  • MTEN 36.6M
  • IPO Year
  • COEP N/A
  • MTEN 2024
  • Fundamental
  • Price
  • COEP $12.45
  • MTEN $5.25
  • Analyst Decision
  • COEP
  • MTEN
  • Analyst Count
  • COEP 0
  • MTEN 0
  • Target Price
  • COEP N/A
  • MTEN N/A
  • AVG Volume (30 Days)
  • COEP 111.8K
  • MTEN 102.7K
  • Earning Date
  • COEP 03-25-2025
  • MTEN 10-18-2024
  • Dividend Yield
  • COEP N/A
  • MTEN N/A
  • EPS Growth
  • COEP N/A
  • MTEN N/A
  • EPS
  • COEP N/A
  • MTEN 0.13
  • Revenue
  • COEP N/A
  • MTEN $9,136,855.00
  • Revenue This Year
  • COEP N/A
  • MTEN N/A
  • Revenue Next Year
  • COEP N/A
  • MTEN N/A
  • P/E Ratio
  • COEP N/A
  • MTEN $40.42
  • Revenue Growth
  • COEP N/A
  • MTEN 18.30
  • 52 Week Low
  • COEP $2.31
  • MTEN $1.81
  • 52 Week High
  • COEP $13.70
  • MTEN $9.87
  • Technical
  • Relative Strength Index (RSI)
  • COEP 63.21
  • MTEN N/A
  • Support Level
  • COEP $8.65
  • MTEN N/A
  • Resistance Level
  • COEP $12.95
  • MTEN N/A
  • Average True Range (ATR)
  • COEP 1.64
  • MTEN 0.00
  • MACD
  • COEP -0.16
  • MTEN 0.00
  • Stochastic Oscillator
  • COEP 75.25
  • MTEN 0.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.

Share on Social Networks: